Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA Works To Clarify Supplement/Food Distinction In Durbin Response

This article was originally published in The Tan Sheet

Executive Summary

Assistant Commissioner Ireland says FDA is preparing a final guidance on distinguishing liquid supplements from conventional beverages, and a guidance on differences between supplements and foods in general could follow. She cites the challenges of distinguishing the categories in a letter responding to Senator Durbin’s questions about regulation of energy drinks.

You may also be interested in...



Baldwin’s Win Bolsters Supplement Caucus In Senate

Tammy Baldwin has been a supplement industry caucus member in the House and stakeholders plan to work with her in the Senate. Trade groups closely track the lame duck session of Congress for proposals that would threaten the supplement industry added to legislation to avoid the federal spending “fiscal cliff.”

Tougher FDA, Congressional “Meddling” With DSHEA Likely In 2013

Compliance with GMPs and other components of DSHEA is not a priority for some firms marketing supplements in the U.S., says contract manufacturing executive Mark Le Doux. “Warning letters … keep pouring out because [firms] either didn’t read the law or they didn’t think they’d be discovered,” he says.

Baldwin’s Win Bolsters Supplement Caucus In Senate

Tammy Baldwin has been a supplement industry caucus member in the House and stakeholders plan to work with her in the Senate. Trade groups closely track the lame duck session of Congress for proposals that would threaten the supplement industry added to legislation to avoid the federal spending “fiscal cliff.”

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS105946

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel